5.05762
(+/-)-Clopidogrel Hydrogensulfate
別名:
(+/-)-Clopidogrel Hydrogensulfate, Purinergic P2Y12 Receptor Antagonist, (+/-)-Clopidogrel, Plavix
ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
実験式（ヒル表記法）:
C16H16ClNO2S · xH2SO4
CAS番号:
分子量:
321.82 (free base basis)
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Storage condition:
OK to freeze, protect from light
assay
≥98% (HPLC)
Quality Segment
form
powder
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, protect from light
color
white
solubility
DMSO: 25 mg/mL
storage temp.
2-8°C
SMILES string
[S](=O)(=O)([O-])O.[s]1c2c(cc1)C[N+H](CC2)C(c3c(cccc3)Cl)C(=O)OC
InChI
1S/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2,1,2,3,4)
InChI key
FDEODCTUSIWGLK-UHFFFAOYSA-N
General description
A thienopyridine compound that acts as a specific irreversible inhibitor of purinergic P2Y12 receptors. Blocks ADP-induced platelet aggregation and serves as an anti-thrombotic agent. Shown to reduce vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression. Clopidogrel is a prodrug that requires activation by CYP enzyme system to produce its pharmacologically active metabolite.
Biochem/physiol Actions
Primary Target
P2Y₁₂
P2Y₁₂
Reversible: no
Preparation Note
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Other Notes
Liu, O., et al. 2012. PLoS One.7, e51707.
Savi, P., et al. 2005. Semin. Thromb. Hemost.31, 174.
Savi, P., et al. 2005. Semin. Thromb. Hemost.31, 174.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Standard Handling (A)
signalword
Danger
Hazard Classifications
Aquatic Chronic 2 - Eye Dam. 1 - Skin Corr. 1B
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
hcodes
保管分類
8A - Combustible corrosive hazardous materials